Laura Jacanin

Senior Director of Business Development
Scroll Down

About Laura Jacanin

Laura Jacanin, Senior Director of Business Development, has had over 20 years of experience in Life Science, including Cell and Gene Therapies and Biologics. With a Masters Degree in Dispute Resolution (Pepperdine School of Law, 2022), she specializes in identifying solutions to develop and expand our offering to meet the demands of the Cell and Gene Therapy market.  For Laura, one of the most exciting parts about supporting therapies into the Clinic is how exceptionally challenging and rewarding it is. At Genezen, Laura engages with external and internal stakeholders to collaborate in the development and production of therapies in and through the Clinic to patients in need.

Why Genezen? Translated from Dutch, the word Genezen means TO CURE. With unique historic expertise in lentiviral and retroviral vectors, Genezen is focused and dedicated to the curative nature of exceptional Gene and Cell Therapies. The Genezen team offers the guidance, expertise, technology, and cGMP manufacturing capacity to help bring your viral vector therapy to patients with accuracy and speed.

I am passionate about: I’m thrilled to have the opportunity to support our clients in their quest to develop and produce life-changing therapies intended to cure.

Meet our People

Our team is dedicated to getting your viral vector where it needs to go. Communication and collaboration are part of our DNA and we can't wait to talk to you about your current challenges and needs.

Ray Kaczmarek

Chief Executive Officer

Bill Vincent

Founder & Executive Chairman

David Anderson

Board Member